Development of a Quality of Life Decision-Making Model for Older Patients with Acute Myeloid Leukemia
老年急性髓系白血病患者生活质量决策模型的开发
基本信息
- 批准号:9973844
- 负责人:
- 金额:$ 15.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-04 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAddressAdult Acute Myeloblastic LeukemiaAffectAftercareAgeAge-YearsBone MarrowCancer CenterCancer SurvivorCaregiversCaringCharacteristicsClinicalClinical ResearchCytogeneticsDecision MakingDependenceDevelopmentDiagnosisDiseaseFamilyFutureGoalsIndividualK-Series Research Career ProgramsKnowledgeLearningLifeMalignant Bone NeoplasmMeasurementMeasuresModelingMonitorNational Institute of Nursing ResearchNewly DiagnosedNursesOutcomePF4 GenePalliative CarePatient PreferencesPatientsPilot ProjectsPopulationPredictive FactorProbabilityProcessPublicationsQuality of lifeRandomized Controlled TrialsResearchResearch DesignResearch PersonnelRiskSiteStatistical MethodsStrategic PlanningSupportive careSurvival RateSymptomsTestingTherapeuticTransfusionUnited States National Institutes of HealthWorkagedassociated symptombaseburden of illnesscareerchemotherapycommon symptomcomorbiditydata managementdesignend of life carefunctional statushigh riskimprovedindividual patientinnovationolder patientoptimal treatmentspatient populationphysical symptompreferenceroutine careskillssymptomatic improvementtreatment as usualtreatment choicetrial comparing
项目摘要
Project Summary/Abstract
Older patients (≥ 60 years of age) with acute myeloid leukemia (AML) do not have enough information,
based on research, to determine the best chemotherapy treatment that aligns with their goals, whether
for survival or improved quality of life (QOL). This proposal seeks to identify significant patient factors and
disease characteristics in order to build a patient decision-making model focused on QOL, while monitoring
survival. This will provide an aid to patients when choosing the most appropriate treatment that optimally aligns
with their goals for care.
This career development award constructs a patient QOL decision-making model integrating significant clinical
disease and patient factor predictors in older patients diagnosed with AML at Moffitt Cancer Center. The
Specific Aims of the research are to: 1) Describe differences in QOL among newly diagnosed older AML
patients receiving intensive versus non-intensive chemotherapy (at baseline and 30, 60, 90 and 180 days
post treatment); 2) Identify the individual clinical disease characteristics (blast percentage, transfusion
dependence, and cytogenetic risk group), and patient factors (age, comorbidities, functional status, and
physical symptoms) of newly diagnosed older AML patients that predict their QOL among those receiving two
treatments, intensive versus non-intensive chemotherapy; 3) Design a patient decision making model
integrating significant clinical disease and patient factor predictors of QOL for newly diagnosed older AML
patients receiving intensive versus non-intensive treatment. Probability will be provided to patients in pie
charts for survival and total QOL score with treatment intensity.
Proposed Career and Learning Objectives are to: 1) Develop expertise in palliative care, focused on the
unique needs of individuals diagnosed with acute myeloid leukemia; 2) Attain skills and knowledge for the
clinical research application of decision-making model research; 3) Attain advanced skills in study design, data
management, measurement, and statistical methods to identify factors; 4) Disseminate findings through
publications and presentations; 5) Develop grantsmanship skills.
Long-term career goal: Randomized controlled trial comparing the alignment of treatment with preferences in
older patients with AML with integration of the model into their care to usual care.
项目总结/摘要
老年急性髓性白血病(AML)患者(≥ 60岁)的信息不足,
根据研究,以确定与他们的目标相一致的最佳化疗治疗,
生存或改善生活质量(QOL)。该提案旨在确定重要的患者因素,
疾病特征,以建立一个病人的决策模型,重点是生活质量,同时监测
生存这将为患者选择最合适的治疗提供帮助,
他们的目标是护理。
该职业发展奖构建了一个患者QOL决策模型,
Moffitt癌症中心诊断为AML的老年患者的疾病和患者因素预测因子。的
研究的具体目的是:1)描述新诊断的老年AML之间的生活质量差异
接受强化与非强化化疗的患者(基线和30、60、90和180天
治疗后); 2)识别个体临床疾病特征(原始细胞百分比,输血
依赖性和细胞遗传学风险组)和患者因素(年龄、合并症、功能状态和
新诊断的老年AML患者的身体症状),预测他们在接受两种治疗的患者中的QOL
治疗,强化与非强化化疗; 3)设计患者决策模型
整合新诊断的老年AML的显著临床疾病和患者因素QOL预测因子
接受强化与非强化治疗的患者。概率将以饼图形式提供给患者
生存率和总QOL评分与治疗强度的图表。
建议的职业和学习目标是:1)发展姑息治疗的专业知识,重点是
诊断为急性髓细胞白血病的个体的独特需求; 2)获得技能和知识,
决策模型研究的临床研究应用; 3)获得研究设计,数据的高级技能
管理、测量和统计方法,以确定因素; 4)通过
出版物和演示文稿; 5)培养专业技能。
长期职业目标:比较治疗与偏好一致性的随机对照试验
老年AML患者将模型整合到他们的护理中,以进行常规护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Tinsley其他文献
Sara Tinsley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Tinsley', 18)}}的其他基金
Development of a Quality of Life Decision-Making Model for Older Patients with Acute Myeloid Leukemia
老年急性髓系白血病患者生活质量决策模型的开发
- 批准号:
10155586 - 财政年份:2020
- 资助金额:
$ 15.79万 - 项目类别:
Development of a Quality of Life Decision-Making Model for Older Patients with Acute Myeloid Leukemia
老年急性髓系白血病患者生活质量决策模型的开发
- 批准号:
10379424 - 财政年份:2020
- 资助金额:
$ 15.79万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant